Literature DB >> 11965499

Clearance of apoptotic beta-cells is reduced in neonatal autoimmune diabetes-prone rats.

B A O'Brien1, W E Fieldus, C J Field, D T Finegood.   

Abstract

The kinetics of beta-cell death in neonatal diabetes-prone (BBdp) and diabetes-resistant (BBdr) BioBreeding rats was investigated using both direct (histochemical) and indirect (mathematical modelling) techniques. In both BBdp and BBdr rats, the incidence of TUNEL positive beta-cells increased until 10 days of age before declining. The number of apoptotic beta-cells was significantly higher in BBdp as compared to BBdr neonates from birth until 20 days of age (P<0.05). Using a mathematical model applied to the time course of beta-cell mass and replication rate, a wave of net beta-cell loss was detected between 10 and 20 days of age in both strains. In contrast to the observed difference in the incidence of TUNEL positive beta-cells, with the model-based approach we found no difference in the rate of beta-cell apoptosis between BBdp and BBdr rats prior to weaning. As the number of apoptotic cells present in a tissue depends on the rate at which cells die and the rate at which the apoptotic cell debris is cleared, we compared in vitro phagocytosis of apoptotic thymocytes by peritoneal macrophages from 2-week-old BBdp and BBdr rats. Macrophages from BBdp neonates engulfed significantly less apoptotic cells as compared to BBdr neonates (P<0.0005). Taken together, these findings suggest that there is impaired clearance of apoptotic beta-cells in diabetes-prone BB rats during the neonatal period.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11965499     DOI: 10.1038/sj.cdd.4400973

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  15 in total

Review 1.  Toxic type 1 diabetes.

Authors:  Mark A Myers; Ian R Mackay; Paul Z Zimmet
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Apoptotic cells can deliver chemotherapeutics to engulfing macrophages and suppress inflammatory cytokine production.

Authors:  Beatriz Perez; Nicholas Paquette; Helena Païdassi; Bo Zhai; Kristin White; Rachel Skvirsky; Adam Lacy-Hulbert; Lynda M Stuart
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

3.  Phagocytic clearance of apoptotic cells: role in lung disease.

Authors:  Jeong H Yun; Peter M Henson; Rubin M Tuder
Journal:  Expert Rev Respir Med       Date:  2008-12       Impact factor: 3.772

4.  Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner.

Authors:  Jenna L Cash; Annabel R Christian; David R Greaves
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

Review 5.  Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.

Authors:  Ashley R Burg; Hubert M Tse
Journal:  Antioxid Redox Signal       Date:  2017-11-27       Impact factor: 8.401

6.  Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis.

Authors:  David B Vaught; Jamie C Stanford; Rebecca S Cook
Journal:  Cancer Cell Microenviron       Date:  2015

7.  Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice.

Authors:  Savita Khanna; Sabyasachi Biswas; Yingli Shang; Eric Collard; Ali Azad; Courtney Kauh; Vineet Bhasker; Gayle M Gordillo; Chandan K Sen; Sashwati Roy
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

8.  Metabolic adaptations to chronic glucose infusion in rats.

Authors:  B G Topp; M D McArthur; D T Finegood
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

Review 9.  Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease.

Authors:  Majid Jaberi-Douraki; Shang Wan Shalon Liu; Massimo Pietropaolo; Anmar Khadra
Journal:  Pediatr Diabetes       Date:  2014-05       Impact factor: 4.866

Review 10.  HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.

Authors:  Shu Zhang; Jixin Zhong; Ping Yang; Feili Gong; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.